Influenza
RSSArticles
-
Pharmacology Update: Influenza Virus Vaccine Live, Intranasal (FluMist)
The FDA has approved the first nasally administered flu vaccine. This cold-adapted, temperature sensitive, attenuated, trivalent vaccine is manufactured by MedImmune Vaccine, Inc. and marketed by MedImmune and Wyeth under the name FluMist. The nasal flu vaccine should be available this fall.